Partnership to support first‑in‑human trial of EPY201 in epilepsy
Source: PharmaTimes
You may also like
POP Health appoints Stephanie O’Hagan as Senior...
Veradermics’ oral treatment for female pattern hair...
AI-Designed Synthetic CRISPR-Like Nucleases Show...
See, Blind Mice: Consortium’s Drugs Restore Sight
Autolomous and Cellular Origins Expand Cell Therapy...
Increased Levels of Micro- and Nanoplastics Found in...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.